Adalimumab/etanercept/infliximabWeight gain: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2012年 / 1400卷 / 1期

关键词：

Public Health; Weight Gain; Infliximab; Etanercept; Alternative Treatment;

D O I：

10.2165/00128415-201214000-00014

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：7 / 7

相关论文

共 50 条

[31] Adalimumab/etanercept/infliximabNeuropathy: 12 case reports
Reactions Weekly, 2016, 1599 (1) : 17 - 17
[32] Adalimumab/etanercept/methotrexateSarcoidosis: 3 case reports
Reactions Weekly, 2012, 1396 (1) : 6 - 6
[33] Adalimumab/etanercept/infliximabLupus: 37 case reports
Reactions Weekly, 2015, 1559 (1) : 17 - 17
[34] Adalimumab/etanercept/infliximabTuberculosis: 6 case reports
Reactions Weekly, 2017, 1672 (1) : 15 - 15
[35] Adalimumab/etanercept/infliximabPsoriasis: 4 case reports
Reactions Weekly, 2008, 1209 (1) : 6 - 6
[36] Adalimumab/etanercept/infliximabPsoriasis: 6 case reports
Reactions Weekly, 2013, 1438 (1) : 5 - 5
[37] Adalimumab/etanercept/infliximabPsoriasis: 25 case reports
Reactions Weekly, 2009, 1241 (1) : 6 - 6
[38] Adalimumab/etanercept/infliximabPsoriasis: 2 case reports
Reactions Weekly, 2016, 1593 (1) : 17 - 17
[39] Adalimumab/etanercept/infliximabMalignancy: 7 case reports
Reactions Weekly, 2015, 1565 (1) : 19 - 19
[40] Adalimumab/etanercept/infliximabTuberculosis: 6 case reports
Reactions Weekly, 2017, 1670 (1) : 15 - 15

← 1 2 3 4 5 →